Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107.92 USD
0.79%
Updated:
Apr 23, 2024
Abbott Laboratories
Free Cash Flow
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Free Cash Flow Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$5.1B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Free Cash Flow
$2.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$1.8B
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Free Cash Flow
$629.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$3.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$749.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
See Also
What is Abbott Laboratories's Free Cash Flow?
Free Cash Flow
5.1B
USD
5.1B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Free Cash Flow amounts to 5.1B USD.
What is Abbott Laboratories's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
9%
9%
Over the last year, the Free Cash Flow growth was -26%. The average annual Free Cash Flow growth rates for Abbott Laboratories have been -13% over the past three years , 3% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
